Web20 jul. 2024 · September 6, 2024 Extraordinary General Meeting of shareholders (EGM) July 20, 2024 Q2 2024 results June 14, 2024 Q2 2024 update April 22, 2024 Annual General Meeting of shareholders (AGM) April 21, 2024 Q1 2024 results Date Presentation Recording March 23, 2024 Integration of Grupo Orbis financials September 27, 2024 Q3 2024 … WebAfter over 25 years of academic research, IonQ was founded in 2015 by Chris Monroe and Jungsang Kim with $2 million in seed funding from New Enterprise Associates, a license to core technology from the University of Maryland and Duke University, and the goal of taking trapped ion quantum computing out of the lab and into the market.
IONIS PHARMACEUTICALS, INC. : Press releases IONS
WebInstitutional investors purchased a net $4.1 million shares of IONS during the quarter ended June 2024, ... ARK Investment Management LLC: 1.88%: 2,673,538: 106,593,960 … WebYour investor relations contact Your investor relations contact Soumya Chandramouli - Chief Financial Officer [email protected] +32 10 47 58 90 Our mission: … rack up + go
Ionis Pharmaceuticals Inc IONS Sustainability - Morningstar
Web23 mrt. 2024 · The Investor Relations website contains information about Incyte's business for stockholders, potential investors, and financial analysts. Skip to main navigation Investor Relations. News . Company Statements Media Contact Email Alerts. Investors . … WebInvestor Relations Investor Information Continuously Improving Our Performance UnitedHealth Group is dedicated to continuously improving the quality of our performance for consumers, customers, care providers and our shareholders. Recommended Q1 Earnings Release Date Scheduled Web9 nov. 2024 · Ionis Pharmaceuticals, Inc. ( NASDAQ: IONS) Q3 2024 Earnings Conference Call November 9, 2024 11:30 AM ET Company Participants Julie Tepper - Investor … rackup